PMID: 15252274Jul 15, 2004Paper

Ziprasidone and weight gain

Clinical Neuropharmacology
Sol JaworowskiHarry Hirsch

Abstract

We describe the case of a 12-year-old white male in whom significant weight gain occurred within 3 months of treatment with Ziprasidone. It is important that clinicians are aware of this possibility since this medication is marketed as one of the few antipsychotic medications not associated with significant weight gain.

References

Feb 24, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T Wetterling
Aug 22, 2001·European Journal of Pharmacology·A W SchmidtS H Zorn
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·K P SuS Y Huang
Aug 8, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J McDougleDavid J Posey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.